Search alternatives:
differences were » differences emerged (Expand Search), differences became (Expand Search), differences model (Expand Search)
marked decrease » marked increase (Expand Search)
differences were » differences emerged (Expand Search), differences became (Expand Search), differences model (Expand Search)
marked decrease » marked increase (Expand Search)
-
1
Linear covariate analysis of prognostically significant metabolites. Presenting the effect sizes of metabolites that showed significant differences among prognostic groups in ICU-treated COVID-19 patients. Metabolites were included based on an F-value > 2.5 and a p-value < 0.05. Metabolites marked with a single asterisk (*) were significant in both two-way ANOVA and ASCA, whereas those marked with double asterisks (**) were significant only in two-way ANOVA....
Published 2025“…Metabolites marked with a single asterisk (*) were significant in both two-way ANOVA and ASCA, whereas those marked with double asterisks (**) were significant only in two-way ANOVA. …”
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
Data_Sheet_1_Immune and Neuroendocrine Trait and State Markers in Psychotic Illness: Decreased Kynurenines Marking Psychotic Exacerbations.docx
Published 2020“…Increased concentrations of IL6, IL8, IL1RA, TNFα, and CCL2 and decreased QA and 3-HK (F8.7–21.0, all p < 0.005) were found in the acute psychotic state and normalized after treatment. …”
-
12
-
13
The number of features that were significantly different between the two groups.
Published 2019“…<p>The number of features that were significantly different between the two groups.…”
-
14
Product ions that were significantly different in breath, stool and plasma.
Published 2021“…<p>Product ions that were significantly different in breath, stool and plasma.…”
-
15
-
16
-
17
-
18
Seventy-five MYB motifs that were significantly expressed in the different tissues.
Published 2019“…<p>Seventy-five MYB motifs that were significantly expressed in the different tissues.…”
-
19
The gene expression profiles of patients with PMR that were in remission after tofacitinib therapy.
Published 2023Subjects: -
20